openPR Logo
Press release

Interleukin 1 (IL1) - Pipeline Review, H1 2017 – MRHs Pharmaceutical Report

06-16-2017 11:55 AM CET | Health & Medicine

Press release from: Medical Industry Reports-[MRH]

Market Research HUB

Market Research HUB

Interleukin 1 (IL1) pipeline Target constitutes close to 28 molecules. Out of which approximately 27 molecules are developed by companies and remaining by the universities/institutes. The latest report Interleukin 1 (IL1) - Pipeline Review, H1 2017, outlays comprehensive information on the Interleukin 1 (IL1) targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type.

Request Free Sample Report: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1157704

Interleukin 1 (IL1) - Interleukin-1 is a cytokine which plays an important role regulation of immune and inflammatory responses. It helps leukocytes pass through blood vessel walls to sites of infection and causes fever by affecting areas of the brain that control body temperature. There are two forms of interleukin-1, alpha and beta. IL-1 stimulates thymocyte proliferation by inducing IL-2 release, B-cell maturation and proliferation, and fibroblast growth factor activity. The molecules developed by companies in Pre-Registration, Phase III, Phase II, Phase I, Preclinical and Discovery stages are 2, 1, 9, 2, 11 and 2 respectively. Similarly, the universities portfolio in Preclinical stages comprises 1 molecules, respectively. Report covers products from therapy areas Dermatology, Musculoskeletal Disorders, Immunology, Metabolic Disorders, Cardiovascular, Oncology, Central Nervous System, Genetic Disorders, Ear Nose Throat Disorders, Gastrointestinal and Genito Urinary System And male/female medicineHormones which include indications Gouty Arthritis (Gout), Acne Vulgaris, Epidermolysis Bullosa, Inflammation, Atherosclerosis, Behcet Disease, Familial Mediterranean Fever, Non-Small Cell Lung Cancer, Rheumatoid Arthritis, Type 2 Diabetes, Alzheimer's Disease, Autoimmune Disorders, Bladder Cancer, Cardiovascular Risk Factors, Colorectal Cancer, Dermatological Disorders, Diabetes, Esophageal Cancer, Fallopian Tube Cancer, Hearing Disorders, Hidradenitis Suppurativa, Hypercholesterolemia, Kidney Fibrosis, Liver Fibrosis, Lymphoma, Metastatic Colorectal Cancer, Mevalonate Kinase Deficiency (Hyperimmunoglobulin D Syndrome (HIDS)), Muckle-Wells Syndrome, Myocardial Infarction, Neonatal Onset Multisystem Inflammatory Disease, Osteoarthritis, Ovarian Cancer, Pain, Peripheral Arterial Disease (PAD)/ Peripheral Vascular Disease (PVD), Plaque Psoriasis (Psoriasis Vulgaris), Prostate Cancer, Restenosis, Sarcoidosis, Skin Inflammation, Systemic Idiopathic Juvenile Arthritis and Tumor Necrosis Factor Receptor-Associated Periodic Syndrome (Familial Hibernian Fever).

Furthermore, this report also reviewsalso reviews key players involved in Interleukin 1 (IL1) targeted therapeutics development with respective active and dormant or discontinued projects. Driven by data and information sourced from proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources.

Make An Enquiry: http://www.marketresearchhub.com/enquiry.php?type=enquiry&repid=1157704

Scope

- The report provides a snapshot of the global therapeutic landscape for Interleukin 1 (IL1)
- The report reviews Interleukin 1 (IL1) targeted therapeutics under development by companies and universities/research institutes based on information derived from company and industry-specific sources
- The report covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages
- The report features descriptive medicine profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities
- The report reviews key players involved in Interleukin 1 (IL1) targeted therapeutics and enlists all their major and minor projects
- The report assesses Interleukin 1 (IL1) targeted therapeutics based on mechanism of action (MoA), route of administration (RoA) and molecule type
- The report summarizes all the dormant and discontinued pipeline projects
- The report reviews latest news and deals related to Interleukin 1 (IL1) targeted therapeutics

Reasons to buy

- Gain strategically significant competitor information, analysis, and insights to formulate effective R&D strategies
- Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
- Identify and understand the targeted therapy areas and indications for Interleukin 1 (IL1)
- Identify the use of medicines for target identification and medicine repurposing
- Identify potential new clients or partners in the target demographic
- Develop strategic initiatives by understanding the focus areas of leading companies
- Plan mergers and acquisitions effectively by identifying key players and its most promising pipeline therapeutics
- Devise corrective measures for pipeline projects by understanding Interleukin 1 (IL1) development landscape
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope

Browse Full Report With TOC: http://www.marketresearchhub.com/report/interleukin-1-il1-pipeline-review-h1-2017-report.html

About Market Research Hub:

Market Research Hub (MRH) is a next-generation reseller of research reports and analysis. MRH’s expansive collection of market research reports has been carefully curated to help key personnel and decision makers across industry verticals to clearly visualize their operating environment and take strategic steps.

MRH functions as an integrated platform for the following products and services: Objective and sound market forecasts, qualitative and quantitative analysis, incisive insight into defining industry trends, and market share estimates. Our reputation lies in delivering value and world-class capabilities to our clients.

Contact Us

90 State Street,
Albany, NY 12207,
United States
Toll Free: 866-997-4948 (US-Canada)
Tel: +1-518-621-2074
Email: press@marketresearchhub.com
Website: http://www.marketresearchhub.com/
Read Industry News At: https://www.industrynewsanalysis.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Interleukin 1 (IL1) - Pipeline Review, H1 2017 – MRHs Pharmaceutical Report here

News-ID: 582662 • Views:

More Releases from Medical Industry Reports-[MRH]

Schistosomiasis Pipeline Insight: Pharmaceutical and Healthcare Report – 2017
Schistosomiasis Pipeline Insight: Pharmaceutical and Healthcare Report – 2017
Market Research Hub (MRH) has recently broadcasted a new study to its broad research portfolio, which is titled as “Schistosomiasis-Pipeline Insights, 2017, report provides comprehensive insights of the ongoing therapeutic research and development across Schistosomiasis. The report provides a complete understanding of the pipeline activities covering all clinical, pre-clinical and discovery stage products. A comparative pipeline therapeutics assessment of Schistosomiasis by development stage, therapy type, route of administration and molecule
Global Atrial Fibrillation Drugs Sales Market Analysis Revealing Key Drivers & Growth Trends through 2022
Global Atrial Fibrillation Drugs Sales Market Analysis Revealing Key Drivers & G …
The report on Atrial Fibrillation Drugs Sales Market is the latest addition to the huge database of Market Research Hub. This research study is segmented on the basis of applications, technology, geography, and types. The Report provides a detailed Atrial Fibrillation Drugs Sales Industry overview along with the analysis of industry’s gross margin, cost structure, consumption value, and sale price. The leading companies of the Atrial Fibrillation Drugs Sales Market,
Global Urology Guidewires Sales Market Report 2017: Share, Size and Industry Forecast
Global Urology Guidewires Sales Market Report 2017: Share, Size and Industry For …
The Market Research Hub’s report offers majority of the latest and newest industry data that covers the overall market situation along with future prospects for Urology Guidewires Sales Market around the globe. The research study includes significant data and also forecasts of the global market which makes the research report a helpful resource for marketing people, analysts, industry executives, consultants, sales and product managers, and other people who are in
Global Breath Analyzers Sales Market Report 2017: Market Analysis Revealing Key Drivers & Growth Trends
Global Breath Analyzers Sales Market Report 2017: Market Analysis Revealing Key …
A latest research report titled as ”Global Breath Analyzers Sales Market Report 2017” has been recently added to the vast portfolio of Market Research Hub (MRH) online research offerings. This report is a professional and in-depth analysis on the present state and future prospect for the global market. It provides valuable information to the industry insiders, potential entrants or investors. It includes an exhaustive enquiry with the reliability of logic

All 5 Releases


More Releases for Interleukin

Interleukin Inhibitors Market | Industry Size, Share, Demand, Manufacturers and …
Interleukin Inhibitors Market Size And Forecast by 2028 The interleukin inhibitors market is expected to gain growth at a potential rate of 14.46% in the forecast period of 2021 to 2028. The rise in awareness amongst the consumers and physicians regarding the benefits of these inhibitors is the factor responsible for the market growth. Explore Further Details about This Research Interleukin Inhibitors Market Report https://www.databridgemarketresearch.com/reports/global-interleukin-inhibitors-market Which are the top companies operating in the
Interleukin 17A Market to see Huge Growth by 2029
The Interleukin 17A Market size is expected to grow at an annual average of CAGR 15% during the forecast period (2023-2029). The role of IL-17 in many inflammatory and autoimmune diseases is now well established, with three currently registered anti-IL-17-targeted therapies. This story has taken place over a period of 20 years and led to the demonstration that a T cell product could regulate, and often amplify, the inflammatory response.
Interleukin Inhibitors Market Size, Share, Forecast, & Industry Analysis 2028
Interleukin inhibitors are the type of immunosuppressive agents, which helps to limit the activity of interleukins. Interleukin is a collection of cytokines which are synthesized by macrophages, lymphocytes, monocytes and certain other cells. Their main function is to standardize the immune system. Browse Related Report: https://blacksocially.com/read-blog/115875 https://anotepad.com/notes/qg2n9b5e https://howtolive.tribe.so/post/interleukin-inhibitors-market-growth-is-14-46-in-the-forecast-period-of-202--64367f9a0adf54905f4f4c16 https://articlescad.com/interleukin-inhibitors-market-growth-is-14-46-in-the-forecast-period-of-2028-169890.html https://www.tamaiaz.com/blogs/52487/Interleukin-Inhibitors-Market-growth-is-14-46-in-the-forecast https://articlescad.com/interleukin-inhibitors-market-growth-is-14-46-in-the-forecast-period-of-2028-169890.html https://rentry.org/iv9sa https://social.kubo.chat/read-blog/8615 https://baskadia.com/post/5qbn https://social.studentb.eu/read-blog/86968 https://pressreleasesubmission8.wordpress.com/2023/04/12/high-grade-bubble-wrap-market-usd-8333-5-million-by-2029/ https://sites.google.com/view/high-gradebubblewrapmarketusd8/home https://www.evernote.com/shard/s415/sh/54c80177-465f-6669-00a6-775def45d65a/etc0XadNNq1TJK8j3e_rky8XzCXK4UFgG_IDxA20vyLKaXfZANkSiDza2w https://diigo.com/0s9xb4 https://dbmrmarket.blogspot.com/2023/04/high-grade-bubble-wrap-market-usd-83335.html https://pastelink.net/g64j5kjq https://network-1062788.mn.co/posts/34973028?utm_source=manual https://penzu.com/journals/28045031/87564724 https://connect.rhabits.io/blogs/227200/High-Grade-Bubble-Wrap-Market-USD-8-333-5-million https://ultrajam.net/merrychriss/blog/4104/high-grade-bubble-wrap-market-usd-83335-million-by-2029 https://bib.az/read-blog/30541 https://wignar.com/read-blog/14654 https://cariblime.net/read-blog/48941 https://blooder.net/read-blog/14280 https://voiced.com/4838/high-grade-bubble-wrap-market-usd-83335-million-by-2029/ https://blacksocially.com/read-blog/115885 https://anotepad.com/notes/ce6xfj3h https://howtolive.tribe.so/post/high-grade-bubble-wrap-market-usd-8-333-5-million-by-2029-the-high-grade-bu--6436832778344d0f25744115 https://articlescad.com/high-grade-bubble-wrap-market-usd-8-333-5-million-by-2029-169900.html https://www.tamaiaz.com/blogs/52501/High-Grade-Bubble-Wrap-Market-USD-8-333-5-million https://tealfeed.com/high-grade-bubble-wrap-market-usd-gwpzw https://rentry.org/5sizk https://social.kubo.chat/read-blog/8619 https://baskadia.com/post/5qby https://social.studentb.eu/read-blog/86977 https://pressreleasesubmission8.wordpress.com/2023/04/12/waterproofing-chemical-market-cagr-of-12-70-forecast-2029/ https://sites.google.com/view/waterproofingchemicalmarketcag/home https://www.evernote.com/shard/s415/sh/d6fd2762-45ed-3320-0af1-9b56fc53f51a/4GImMKdUtFU60C6McYjSS-GSaGkTmbgMj1pe69eWkObfyGsTkcF0GCIm6A https://diigo.com/0s9xr5 https://dbmrmarket.blogspot.com/2023/04/waterproofing-chemical-market-cagr-of.html https://pastelink.net/18g8os0b https://network-1062788.mn.co/posts/34973904?utm_source=manual https://penzu.com/journals/28045031/87565177 https://connect.rhabits.io/blogs/227206/Waterproofing-Chemical-Market-CAGR-of-12-70-Forecast-2029 https://ultrajam.net/blog/create https://bib.az/read-blog/30548 https://wignar.com/read-blog/14657 https://cariblime.net/read-blog/48962 https://blooder.net/read-blog/14288 https://voiced.com/4841/waterproofing-chemical-market-cagr-of-1270-forecast-2029/ Contact Us:- Data Bridge Market Research US: +1 888 387 2818 UK: +44 208 089 1725 Hong Kong: +852 8192 7475 Email:- corporatesales@databridgemarketresearch.com About Data Bridge Market Research: An absolute way to forecast what
IL6 (Interleukin-6 Precursor) Market 2022 | Detailed Report
The IL6 (Interleukin-6 Precursor) report understands the current and future competitive scenario across types, countries, and applications.It provides accurate, up-to-date analysis of markets and companies.The report use reliable information and analysis to gain a deeper understanding of the current factors impacting the industry. The IL6 (Interleukin-6 Precursor) report provides exact and accurate data that helps companies of all sizes to make timely decisions. Furthermore, the report provides robust solutions to customers,
Interleukin 12 Receptor Market Research Report 2015-2025
About the Global Interleukin 12 Receptor Market Research Report 2015-2025: Global Interleukin 12 Receptor Market Research Report 2015-2025 is divided into various key segments like device type, material, applications, and end users. The report is thoroughly analyzed and studied by the researchers to offer deep insights on each of these segments with statistics. This information is beneficial for the manufacturers in the industry to plan their policies and strategies accordingly and
Interleukin-6 Inhibitors Therapeutics Pipeline a Solution to Various Diseases
Interleukin-6 (IL-6), an inflammatory cytokine involved in various biological processes, ranging from immune system activation and hematopoiesis to inflammation and regulating oncogenesis by taking part in gene activation and cell proliferation, survival, and differentiation. The receptor for this ligand (IL-6) is composed of two subunits — an alpha subunit responsible for ligand specificity, and glycoprotein (GP) 130, a receptor that other cytokines in the IL-6 family share. The Ras-mediated and